MTD-comsia modelling of HMG-CoA reductase inhibitors
Author(s) -
Daniel Duda-Seiman,
Speranța Avram,
Silvia Mancaş,
Valentin Careja,
Corina Duda-Seiman,
Mihai V. Putz,
Dan Ciubotariu
Publication year - 2011
Publication title -
journal of the serbian chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.227
H-Index - 45
eISSN - 1820-7421
pISSN - 0352-5139
DOI - 10.2298/jsc100601019d
Subject(s) - steric effects , reductase , hydrogen bond , chemistry , hmg coa reductase , stereochemistry , acceptor , enzyme , biochemistry , molecule , organic chemistry , physics , condensed matter physics
The 3D quantitative structure-activity relationship for a series of hy- droxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors based on the pyr- rolylethyl-tetrahydropyranone scaffold was examined using the Minimal Topo- logical Difference (MTD) method and comparative molecular similarity index analysis (CoMSIA). The studied compounds were of the tetrahydro-4-hydroxy- -6-(2-(1H-pyrrol-1-yl)ethyl)-2H-pyran-2-one type. In clinical practice, HMG- -CoA reductase inhibitors are usually referred to by the generic name statins. The analysis performed using the MTD method showed that voluminous sub- stituents produce a significant biological activity ( 2 CV R = 0.677 > 0.5; SEECV = = 0.319), while the CoMSIA method added useful information regarding the influence of the steric, electrostatic, hydrophobic, hydrogen bond donor, and acceptor properties on biological activity ( 2 CV R = 0.60; r 2 = 0.98).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom